HT Supreme
Commercial- Indications
- Coronary artery disease
Company intelligence / Profile preview
SINOMED
Tianjin, Tianjin, Chinasinomed.com ↗
- Ownership
- Public · 688108
- Development stage
- Commercial
01
Overview
SINOMED is a global leader in interventional medical devices with commercialized products such as drug-eluting coronary and neurovascular stents. The company completed pivotal global trials for its BuMA Supreme DES and is pursuing regulatory approvals in the US and Japan. Its AccuFit TMVR system has gained attention worldwide, while its NOVA DES is the first healing-targeted neuro-interventional drug-eluting stent. The company also manufactures a wide range of finished pharmaceuticals through its pharmaceutical division.
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Drug-eluting stentTranscatheter mitral valve replacement systemIntracranial drug-eluting stent systemFinished pharmaceuticals (tablets, capsules, injections)
- Industry
- Implantable Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Not explicitly listed; collaborates with academic leaders and hospitals globally for clinical studies
Beyond the preview
Go deeper on SINOMED.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SINOMED.